Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3578 Target Snapshot

Aldehyde dehydrogenase, dimeric NADP-preferring · SINGLE PROTEIN · Homo sapiens

187Compounds
42Assays
0Approved Drugs
168.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P30838. Use UniProt P30838 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P30838 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Aldehyde dehydrogenase, dimeric NADP-preferring as ChEMBL target CHEMBL3578, mapped to UniProt P30838. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Aldehyde dehydrogenase, dimeric NADP-preferring
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3578
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P30838
Aldehyde dehydrogenase, dimeric NADP-preferring
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Aldehyde dehydrogenase, dimeric NADP-preferring is the right protein anchor across sources, using UniProt P30838 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAldehyde dehydrogenase, dimeric NADP-preferring
UniProt AccessionP30838
Component TypeProtein
Sequence Length453 aa

Aldehyde dehydrogenase, dimeric NADP-preferring

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Aldehyde dehydrogenase, dimeric NADP-preferring, mapped to UniProt P30838. Sequence length is 453 aa.

Mapped IDP30838
Review nameAldehyde dehydrogenase, dimeric NADP-preferring
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC50157.0
KI11.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1378094 7.09 Ki 82.0 Preclinical
CHEMBL4745360 6.71 IC50 193.0 Preclinical
CHEMBL1378094 6.7 IC50 200.0 Preclinical
CHEMBL4754311 6.66 IC50 219.0 Preclinical
CHEMBL4777582 6.66 IC50 219.0 Preclinical
CHEMBL4753971 6.62 IC50 241.0 Preclinical
CHEMBL5076191 6.62 Ki 240.0 Preclinical
CHEMBL4755837 6.61 IC50 246.0 Preclinical
CHEMBL4791741 6.61 IC50 246.0 Preclinical
CHEMBL4763602 6.6 IC50 251.0 Preclinical
Distribution

pChEMBL Value Distribution

18
5.0
33
5.5
22
6.0
19
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

42
Total Assays
103
Tested Compounds
2
Assay Types
Binding — 38 assays, 103 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 23 81 5.6
cell-based format 10 0
assay format 5 22 5.7
ADME — 4 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 4 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine